TickerFacts.

Compare

ANI Pharmaceuticals Inc vs Arrowhead Pharmaceuticals, Inc. vs Madrigal Pharmaceuticals, Inc. vs Corcept Therapeutics Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearANI Pharmaceuticals Inc
ANIP		Arrowhead Pharmaceuticals, Inc.
ARWR		Madrigal Pharmaceuticals, Inc.
MDGL		Corcept Therapeutics Inc
CORT
Year ended2025-12-312025-09-302025-12-312025-12-31
Revenue$883.37M$829.45M$958.40M$761.41M
Revenue growth (YoY)+43.8%n/m+432.1%+12.8%
Gross marginn/an/an/an/a
Operating margin12.6%11.9%-31.3%5.9%
Net margin8.9%3.6%-30.1%13.1%
Net income$78.34M$30.11M-$288.28M$99.65M
EPS (Diluted)$3.32-$0.01-$12.85$0.82
Operating cash flow$185.22M$179.55M-$189.55M$142.00M
Free cash flow$171.39M$156.89M-$190.02M$141.78M
Cash & equivalents$285.58Mn/a$198.69M$120.50M
Total assets$1.44B$1.39B$1.26B$836.65M
Total liabilities$899.65Mn/a$656.90M$188.85M
Shareholders' equity$540.72M$503.42M$602.69M$647.80M
Return on year-end equity14.5%6.0%-47.8%15.4%
Shares outstanding22.49M135.70M22.84M105.97M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearANI Pharmaceuticals IncArrowhead Pharmaceuticals, Inc.Madrigal Pharmaceuticals, Inc.Corcept Therapeutics Inc
Latest$883.37M
Ended 2025-12-31		$829.45M
Ended 2025-09-30		$958.40M
Ended 2025-12-31		$761.41M
Ended 2025-12-31
1 year earlier$614.38M
Ended 2024-12-31		$3.55M
Ended 2024-09-30		$180.13M
Ended 2024-12-31		$675.04M
Ended 2024-12-31
2 years earlier$486.82M
Ended 2023-12-31		$240.74M
Ended 2023-09-30		$0
Ended 2023-12-31		$482.38M
Ended 2023-12-31
3 years earlier$316.38M
Ended 2022-12-31		$243.23M
Ended 2022-09-30		$0
Ended 2022-12-31		$401.86M
Ended 2022-12-31
4 years earlier$216.14M
Ended 2021-12-31		$138.29M
Ended 2021-09-30		$0
Ended 2021-12-31		$365.98M
Ended 2021-12-31